NASHVILLE, Tenn.--(BUSINESS WIRE)--Sarah Cannon, the global cancer institute of Hospital Corporation of America (HCA), and HCA Midwest Health, Kansas City’s largest healthcare network, announced today that they have expanded their cancer collaboration through clinical research. By joining a global research network, HCA Midwest Health is offering greater access to clinical trials for those facing cancer in the Kansas City region.
“Clinical trials are an integral part of advancing the standard of cancer care, as today’s trials are tomorrow’s cutting-edge treatments,” said Howard A. "Skip" Burris, III, MD, President of Clinical Operations and Chief Medical Officer at Sarah Cannon. “By expanding our collaboration, we can provide patients in Kansas City access to the latest therapies with the comfort of their physicians, family and friends close to home.”
Patients can access clinical trials throughout the entire HCA Midwest Health system. The initial strategic research sites where Sarah Cannon clinical trials will be conducted in the coming weeks include Menorah Medical Center and Research Medical Center. Additional sites are planned to launch in the near future. With expert investigators who specialize in several areas of cancer including hematology, gynecology and neuro-oncology, Sarah Cannon Research Institute at HCA Midwest Health has the capabilities and experience to conduct a wide variety of clinical trials.
Since 2014, HCA Midwest Health and Sarah Cannon have worked together to advance cancer services in Kansas City. Sarah Cannon Research Institute at HCA Midwest Health will be supported and complemented by the system’s seven hospitals, Belton Regional Medical Center, Centerpoint Medical Center, Lafayette Regional Health Center, Lee's Summit Medical Center, Menorah Medical Center, Overland Park Regional Medical Center and Research Medical Center as well as numerous cancer care outreach sites located in communities throughout the region.
“Sarah Cannon is at the forefront of international cancer research, leading studies for approximately 80 percent of approved therapies over the last decade,” said Jaswinder Singh, MD, Medical Director, Clinical Research, Sarah Cannon at HCA Midwest Health. “HCA Midwest Health has long been recognized for our strong physician leadership and clinical excellence in cancer care delivery. By working with a global network of experts, we can offer our patients seeking new treatment options even greater access to potentially life-saving therapies in our communities.”
Sarah Cannon Research Institute is the arm of Sarah Cannon that conducts over 500 community-based trials through affiliations with 1,000+ physicians across the United States and United Kingdom. Through its research program, Sarah Cannon enrolls more than 2,000 cancer patients to studies annually.
About HCA Midwest Health
HCA Midwest Health is the Kansas City area’s leading healthcare provider consisting of seven hospitals, outpatient centers, clinics, physician practices, surgery centers and an array of other services to meet the healthcare needs of the greater Kansas City area. HCA Midwest Health is also one of the area’s largest private sector employers with more than 9,000 employees, the largest provider of charity and uncompensated care, and annually donates more than $1.2 million to local charities. Since April 2003, HCA Midwest Health has invested more than $845 million to enhance and expand patient services and has paid more than $216 million in taxes to local communities. HCA Midwest Health facilities serving the Kansas City area include Belton Regional Medical Center, Centerpoint Medical Center, Lafayette Regional Health Center, Lee's Summit Medical Center, Menorah Medical Center, Overland Park Regional Medical Center, Research Medical Center and Research Psychiatric Center. Midwest Physicians, which is part of HCA Midwest Health, is a network of experienced, multi-specialty physicians located throughout the Greater Kansas City metropolitan area. Midwest Physicians currently represents 344 physicians, including 142 primary care providers and 197 specialists with 80 physician practices providing care in 146 locations to serve the community. The physicians, licensed professionals and support staff who comprise the HCA Midwest Health team are dedicated to improving healthcare in the Greater Kansas City and outlying areas. For more information, visit hcamidwest.com.
About Sarah Cannon Research Institute
Sarah Cannon Research Institute is the research arm of HCA’s global cancer institute, Sarah Cannon. Focused on advancing therapies for patients, it is one of the world’s leading clinical research organizations conducting community-based clinical trials through affiliations with a network of more than 1,000 physicians across the United States and United Kingdom. Sarah Cannon has led more than 200 first-in-man clinical trials since its inception in 1993, and has been a clinical trial leader in nearly 80 percent of approved cancer therapies in the last 10 years. Additionally, Sarah Cannon offers management, regulatory, and other research support services for drug development and industry sponsors, as well as strategic investigator sites through its contract research organization. For more information, visit sarahcannon.com.